HIV-1 p17 Gag 77-86 (HLA-A*02:01) SLYNTVATLY
€210.00*
Description
SLYNTVATLY is a linear peptidic epitope (epitope ID 190980) studied as part of Gag polyprotein from Human immunodeficiency virus 1 and Gag-Pol polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays Antigen Peptide HIV-1 p17 Gag 77-86 (HLA-A*02:01) SLYNTVATLY for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.SLYNTVATLY is a linear peptidic epitope (epitope ID 190980) studied as part of Gag polyprotein from Human immunodeficiency virus 1 and Gag-Pol polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays Antigen Peptide HIV-1 p17 Gag 77-86 (HLA-A*02:01) SLYNTVATLY for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
TechData
| Sequence: | SLYNTVATLY |
| Gene: | gag-pol |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Gag-Pol polyprotein |
| Species: | Human immunodeficiency virus 1 (HIV-1) |
| Allele: | HLA-A*02:01 |
| Application: | Flow Cytometry, Immunohistochemistry |
| Indication: | Infectious disease |
| Purity: | 95% HPLC-MS |